Acquiring Company
ARCHIMED
Acquired Company
Esperion Therapeutics
Ann ArborFinancial ServicesHealth CareVenture CapitalMedicalventure capital & private equityBiotechnologyHealth CareTherapeuticsPharmaceuticalpharmaceuticalsDescription
Esperion Therapeutics, Inc. is set to be acquired by funds managed by ARCHIMED. Esperion shareholders will receive $3.16 per share in cash along with the chance for additional payments. This acquisition aims to foster growth and enhance shareholder value.
Quick answer
ARCHIMED is acquiring Esperion Therapeutics, announced May 6, 2026.
- How much did ARCHIMED pay for Esperion Therapeutics?
- The deal value was not disclosed.
- What does ARCHIMED do?
- ARCHIMED is a private equity firm focusing on the healthcare sector.
- Where are ARCHIMED and Esperion Therapeutics based?
- Esperion Therapeutics is based in Ann Arbor, Michigan, United States.
- Who are the decision-makers at ARCHIMED?
- Fundz holds 1 contact at ARCHIMED. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Venture Capital
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lupin completes acquisition of VISUfarma (April 2, 2026)
- Eli Lilly to acquire Ajax Therapeutics for $2.3B, $2.3B (April 27, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- Otsuka acquires Transcend Therapeutics for $700M, $700M (June 12, 2026)
- GSK to acquire Nuvalent for $10.6 billion, $11B (June 9, 2026)
- Galmed Pharmaceuticals to acquire Colospan for GI focus (June 8, 2026)
Who to call at ARCHIMED, and when
When ARCHIMED changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ARCHIMED raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARCHIMED, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARCHIMED. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARCHIMED makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Esperion Therapeutics?
Esperion Therapeutics was acquired by ARCHIMED. The deal was reported on May 6, 2026. ARCHIMED is a private equity firm focusing on the healthcare sector. It invests in and supports companies that provide innovative solutions in medical technology and services. ARCHIMED is privately held and operates in Financial Services.
When did ARCHIMED acquire Esperion Therapeutics?
ARCHIMED's acquisition of Esperion Therapeutics was reported on May 6, 2026. Esperion Therapeutics, Inc. is set to be acquired by funds managed by ARCHIMED. Esperion shareholders will receive $3.16 per share in cash along with the chance for additional payments. This acquisition aims to foster growth and enhance shareholder value. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Esperion Therapeutics do?
Esperion Therapeutics is a pharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative medicines for patients at risk for cardiovascular and cardiometabolic diseases. It is privately held, operating in Biotechnology, and is based in Ann Arbor.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.